English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 916242 Online Users : 1422
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
分子與基因醫學研究所
生技與藥物研究所
生醫工程與奈米醫學研究所
免疫醫學研究中心
神經及精神醫學研究中心
細胞及系統醫學研究所
感染症與疫苗研究所
群體健康科學研究所
癌症研究所
國家環境醫學研究所
國家蚊媒傳染病防治研究中心
高齡醫學暨健康福祉研究中心
論壇
生醫資源中心
研究生培育合作學程
核心儀器設施中心
病理核心實驗室
實驗動物中心
行政管理部門
圖書館
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
Browse all
Communities
& Collections
Title
Authors
Date
Data Type
News and Activites
新增論文清單
,歡迎閱覽
(113/11/12)
。
機構典藏系統資料若需新增或戡誤,請洽圖書館
連瓊勻館員
(#33646)
或
陳雅琪館員
(#33642)
Relevant Link
國衛院首頁
國衛院圖書館首頁
國家衛生研究院 NHRI
>
Browse by Title
Loading...
Jump to:
[
Chinese Items
] [
0-9
] [
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
]
or enter the first few letters:
Showing items 1751-1760 of 12927. (1293 Page(s) Totally)
<<
<
171
172
173
174
175
176
177
178
179
180
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2004-07-01
BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo
Cancer Research. 2004 Jul;64(13):4621-4628.
2012-01
BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML
British Journal of Cancer. 2012 Jan;106(3):475-481.
2012-11
BPR1J271, a novel FLT3 inhibitor for treating acute myeloid leukemia
European Journal of Cancer. 2012 Nov;48(Suppl. 6):53-54.
2018-08-24
BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor
Cancer Science. 2018 Nov;109(11):3591-3601.
2016-10
BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia
Molecular Cancer Therapeutics. 2016 Oct;15(10):2323-2333.
2011-08
BPR1K653, a novel aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cells
PLoS ONE. 2011 Aug;6(8):Article number e23485.
2011-09-23
BPR1K653, a novel Aurora Kinase Inhibitor, exhibits potent anti-proliferative activity in P-gp170 (MDR1)-mediated VX680-resistant cancer cells in vitro and in vivo
European Journal of Cancer. 2011 Sep 23;47:S127.
2020-04
BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine
Neuropharmacology. 2020 Apr;166:Article number 107678.
2010-01
BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses
Journal of Antimicrobial Chemotherapy. 2010 Jan;65(1):63-71.
2015-08
BPR2P001S0, a Coumarin derivative, induced cell cycle arrest in A549 through inhibiting PDPK1 activity
Cancer Research. 2015 Aug;75:Abstract number 1754.
Showing items 1751-1760 of 12927. (1293 Page(s) Totally)
<<
<
171
172
173
174
175
176
177
178
179
180
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback